How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Close this folder9 REVIEW AND UPDATE
View the documentPlanning for review
View the documentHow frequently does the national formulary need to be reviewed?
Close this folderReview process
View the documentIdentification of areas in need of change
View the documentDrafting of updated texts for areas where change is necessary
View the documentUpdating texts based on the WHO model formulary
View the documentUpdating texts containing locally added information
View the documentApproval by the national formulary committee and expert advisers
View the documentREFERENCES
 

Approval by the national formulary committee and expert advisers

Any new alterations, additions or deletions should be carefully documented, the revised text proofread and assessed by the editorial committee and approved by the NFC. Depending on the extent of the changes, circulation of certain revised chapters to expert advisers may be necessary to check clarity and comprehensibility.

In addition to the cost of production, regular meetings, good communication and adequate funding to support these and related activities will be essential for timely review.

The final editing and production issues will be similar to those already discussed above.

It is important to remember that careful planning, a skilled editorial team, involvement of local experts, adequate resources and sufficient time will all be necessary for the successful production of the formulary.

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014